JPMorgan Sees Risk of ‘Modest’ Stock Drop But Don’t Go Defensive
(Bloomberg) -- There's a risk of a modest equity-market correction in the next couple of weeks if economic data miss expectations, according to JPMorgan Chase & Co.
A large stock-market tumble is unlikely given pent-up demand and an assumption that further fiscal relief will eventually pass Congress, keeping the economy “well above trend,” strategists including John Normand wrote in a note Friday. However, there are moderate risks from payrolls and retail sales data undershooting expectations in the early part of the month, they warned.
“Some misgivings are justified given a macro backdrop that is becoming muddied, but not muddied enough to justify bearish targets or a defensive investment strategy,” the strategists wrote. “The intersection of a U.S. growth downshift with expiring income supports preserves the risk of a market correction in August, but drawdown should be limited due to investor positioning.”
The S&P 500 has risen 46% from its March low on the back of unprecedented fiscal and monetary stimulus to combat the impact of Covid-19. As the benchmark climbed, numerous market watchers have warned that a pullback is likely, and corporate insiders have started to sell stocks.
Normand -- who not long after the March trough said that the worst was likely over -- maintains that conditions aren't in place for much of a drawdown right now.
“A large correction (about 10%) would be tough to generate when positioning measures in equities are below average for most hedge funds” as well as for balanced bond/equity mutual funds,” the JPMorgan strategists said.
©2020 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.